Expertise in
3
conditions

Jianxin X. Xue

37 Guoxue Lane, 610041, 
Chengdu, CN 
Expertise in
3
conditions
37 Guoxue Lane, 610041, 
Chengdu, CN 

Overview

Jianxin Xue practices practicing medicine in Chengdu, China.

Xue is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 1 clinical trial.

Locations

37 Guoxue Lane, 610041, Chengdu, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer
A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drugs: Tislelizumab+Cisplatin or Carboplatin+Pemetrexed, Cisplatin or Carboplatin+Pemetrexed
Study Phase: Phase 3

105 Total Publications

Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation.
Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation.
Journal: Molecular cancer
Published: April 13, 2026

Frequently Asked Questions about Jianxin X. Xue

Is Jianxin X. Xue a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jianxin X. Xue is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jianxin X. Xue participate in research or clinical trials?

Yes. Jianxin X. Xue has published 105 articles and abstracts on conditions like Lung Cancer. You can view a list of Jianxin X. Xue's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xue's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile